Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. [electronic resource]
Producer: 20071214Description: 2804-10 p. digitalISSN:- 1935-5548
- Blood Glucose -- analysis
- Blood Pressure -- drug effects
- Bread
- C-Reactive Protein -- drug effects
- Cardiovascular Diseases -- prevention & control
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- prevention & control
- Dietary Fiber
- Dietary Supplements
- Edible Grain
- Glycated Hemoglobin -- metabolism
- Humans
- Insulin -- blood
- International Normalized Ratio
- Lipids -- blood
- Prothrombin Time
- Risk Factors
- Salvia
- Single-Blind Method
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.